Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 17, 2008 - Issue 1
Submit an article Journal homepage
209
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Update: vildagliptin for the treatment of Type 2 diabetes

Alan J Garber Professor of Medicine, Biochemistry & Molecular Biology, and Molecular & Cellular Biology, Baylor College of Medicine, Division of Diabetes, Endocrinology & Metabolism, 1709 Dryden, Suite 1000, Houston, TX 77030, USA +1 713 798 0230; +1 713 798 2750; [email protected]
, MD PhD &
Morali D Sharma Assistant Professor of Medicine, Baylor College of Medicine, Division of Diabetes, Endocrinology & Metabolism, 1709 Dryden, Suite 1000, Houston, TX 77030, USA
, MD
Pages 105-113 | Published online: 20 Dec 2007

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sharif Arar, Enas Al-Qudah, Muhammad Alzweiri & Kamal Sweidan. (2020) New forced degradation products of vildagliptin: Identification and structural elucidation using LC-MS, with proposed formation mechanisms. Journal of Liquid Chromatography & Related Technologies 43:15-16, pages 633-644.
Read now
Baptist Gallwitz. (2010) New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin. Diabetes, Metabolic Syndrome and Obesity 3, pages 117-124.
Read now
S. Halimi, D. Raccah, A. Schweizer & S. Dejager. (2010) Role of vildagliptin in managing type 2 diabetes mellitus in the elderly. Current Medical Research and Opinion 26:7, pages 1647-1656.
Read now

Articles from other publishers (11)

Vikas Rathod, Pankaj Saini, Ramandeep Kaur, Srinivasa Marimganti & Kamlesh J. Ranbhan. (2023) A Critical Account of Synthetic Approaches toward Vildagliptin, an Antidiabetic Drug. Organic Process Research & Development 27:11, pages 1880-1899.
Crossref
Gamze Argun-Kurum, Fatma Kaya-Dagistanli & Melek Ozturk. (2019) DPP4 inhibitor induces beta cell regeneration and DDR-1 protein expression as an endocrine progenitor cell marker in neonatal STZ-diabetic rats. Pharmacological Reports 71:4, pages 721-731.
Crossref
Agnieszka Strózik, Arkadiusz Stęposz, Marcin Basiak, Magdalena Drożdż & Bogusław Okopień. (2015) Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus. Pharmacological Reports 67:1, pages 24-31.
Crossref
Graham T. McMahon. 2010. Principles of Diabetes Mellitus. Principles of Diabetes Mellitus 787 800 .
D. Devendra, B. Gohel, V. Bravis, E. Hui, S. Salih, S. Mehar & M. Hassanein. (2009) Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. International Journal of Clinical Practice 63:10, pages 1446-1450.
Crossref
Kiwon Ban, Sonya Hui, Daniel J. Drucker & Mansoor Husain. (2009) Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies. Journal of the American Society of Hypertension 3:4, pages 245-259.
Crossref
E. Ferrannini, V. Fonseca, B. Zinman, D. Matthews, B. Ahrén, S. Byiers, Q. Shao & S. Dejager. (2009) Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diabetes, Obesity and Metabolism 11:2, pages 157-166.
Crossref
Anne-Marie Lambeir, Simon Scharpé & Ingrid De Meester. (2008) DPP4 inhibitors for diabetes—What next?. Biochemical Pharmacology 76:12, pages 1637-1643.
Crossref
S. Dejager & A. Grimaldi. (2008) Association gliptines et sulfamides hypoglycémiants. Médecine des Maladies Métaboliques 2:6, pages 620-625.
Crossref
Jamie D Croxtall & Susan J Keam. (2008) Vildagliptin. Drugs 68:16, pages 2387-2409.
Crossref
Shridhar Hegde & Michelle Schmidt. 2008. 455 497 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.